Why Manual Excursion Investigation Takes Days
The investigation cycle is slow because it's sequential. Someone has to pull the Sensitech TempTale data, then cross-reference the product-specific stability matrix to determine whether the recorded excursion profile falls within qualified limits, then document the assessment in MasterControl, then route it to QA for review before the sponsor's medical monitor can make the patient use/no-use call. Each handoff adds hours, and the manual data-pull-and-cross-reference step at the beginning often takes a full business day on its own. Meanwhile, the patient is waiting.
Automated Excursion Assessment and Routing
An AI Labor Company agent learns your cold chain excursion investigation logic from Sensitech TempTale data patterns and MasterControl investigation histories. In production, when an excursion alert triggers, the agent automatically pulls the TempTale temperature profile, cross-references the product stability matrix for the specific CAR-T product and excursion parameters, generates a preliminary patient impact assessment, and creates a structured investigation record in MasterControl — all within four hours of the alert. The assessment is queued for the clinical supply director's review and Slack-notified for immediate attention, enabling same-day routing to the sponsor's medical monitor.
The Business Case: Patient Safety and Program Risk Reduction
The primary value here isn't efficiency — it's risk elimination. A five-to-seven-day excursion investigation in a Phase II CAR-T trial creates real risks: delayed patient treatment, product disposal under uncertainty when stability data would have supported use, and the reputational and regulatory exposure of a CDMO whose investigation process doesn't match the urgency of the product. Compressing excursion-to-assessment from days to under twenty-four hours protects patients, protects the trial timeline, and demonstrates to sponsors the operational quality standard they're paying for. The agent is typically live and integrated with your TempTale and MasterControl environment within eight weeks.
Does the agent handle multiple CAR-T product stability matrices or just one product?
The agent is configured with the stability matrix for each product in your clinical supply portfolio. When an excursion occurs, it identifies the correct product and applies the appropriate matrix automatically based on the shipment record.
What if the TempTale data is ambiguous — for example, a sensor malfunction mid-shipment?
The agent flags sensor gaps or data quality issues in the preliminary assessment as conditions requiring manual review before a use/no-use determination. It doesn't generate a clean assessment on incomplete data — it escalates with the specific issue documented.
How does the agent interact with the sponsor's medical monitor — does it send them directly?
The investigation record and patient impact assessment are queued for the clinical supply director's review and approval first. Once approved, the director routes to the sponsor's medical monitor through your established communication channel. The agent doesn't bypass your QA oversight layer.